YY1 and cholangiocarcinoma: Also, YY1 had been shown to be involved in various tumors progression and associated with adverse clinical prognosis in tumor patients, for instance, YY1 stimulated LINC00667 transcription that enhanced the proliferation of cholangiocarcinoma [26].